Abcellera Biologics logo

Abcellera Biologics Share Price Today (NASDAQ: ABCL)

Abcellera Biologics share price is $3.42 & ₹293.05 as on 1 Jul 2025, 01.30 'hrs' IST

$3.42

-0.19

(-5.26%)

Market is closed - opens 7 PM, 01 Jul 2025

View live Abcellera Biologics share price in Dollar and Rupees. Guide to invest in Abcellera Biologics stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Abcellera Biologics, along with analyst recommendations, forecasts, and comprehensive financials.

Abcellera Biologics share price movements

  • Today's Low: $3.42
    Today's High: $3.75

    Day's Volatility :8.68%

  • 52 Weeks Low: $1.89
    52 Weeks High: $4.09

    52 Weeks Volatility :53.72%

Abcellera Biologics (ABCL) Returns

PeriodAbcellera Biologics IncSector (Health Care)Index (Russel 2000)
3 Months
72.73%
-7.3%
0.0%
6 Months
23.21%
-2.4%
0.0%
1 Year
29.86%
-8.1%
0.0%
3 Years
-65.22%
4.4%
3.6%

Abcellera Biologics (ABCL) Key Statistics

in dollars & INR

Previous Close
$3.61
Open
$3.64
Today's High
$3.745
Today's Low
$3.42
Market Capitalization
$1.1B
Today's Volume
$6.2M
52 Week High
$4.085
52 Week Low
$1.8906
Revenue TTM
$23.1M
EBITDA
$-231.2M
Earnings Per Share (EPS)
$-0.56
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.46%
Return On Equity TTM
-15.6%

How to invest in Abcellera Biologics Stock (ABCL) from India?

It is very easy for Indian residents to invest directly in Abcellera Biologics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Abcellera Biologics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Abcellera Biologics or ABCL on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Abcellera Biologics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Abcellera Biologics shares which would translate to 0.251 fractional shares of Abcellera Biologics as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India , including recognised companies like Abcellera Biologics, in just a few clicks!

Returns in Abcellera Biologics (ABCL) for Indian investors in Rupees

The Abcellera Biologics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Abcellera Biologics investment value today

Current value as on today

₹1,25,810

Returns

₹25,810

(+25.81%)

Returns from Abcellera Biologics Stock

₹23,022 (+23.02%)

Dollar Returns*

₹2,788 (+2.79%)

Indian investors sentiment towards Abcellera Biologics (ABCL)

47.06%

Period: May 31, 2025 to Jun 30, 2025. Change in 30 Days versus previous period

Investment in Abcellera Biologics Shares from India has grown by 47.06% over the past 30 days, indicating increased transactional activity.

289%

Period: May 31, 2025 to Jun 30, 2025. Change in 30 Days versus previous period

Search interest for Abcellera Biologics Stock from India on INDmoney has increased by 289% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Abcellera Biologics

  • Baker Bros Advisors LP

    9.22%

  • ING Investment Management LLC

    7.12%

  • UBS Asset Mgmt Americas Inc

    5.25%

  • Capital World Investors

    4.48%

  • Baillie Gifford & Co Limited.

    3.75%

  • UBS Group AG

    1.70%

Analyst Recommendation on Abcellera Biologics

Rating
Trend

Buy

    93%Buy

    6%Hold

    0%Sell

Based on 15 Wall street analysts offering stock ratings for Abcellera Biologics(by analysts ranked 0 to 5 stars)

Analyst Forecast on Abcellera Biologics Stock (ABCL)

What analysts predicted

Upside of 146.45%

Target:

$8.43

Current:

$3.42

Insights on Abcellera Biologics Stock (Ticker Symbol: ABCL)

  • Price Movement

    In the last 7 days, ABCL stock has moved up by 8.4%
  • Decreasing Revenue

    Revenue is down for the last 5 quarters, 9.95M → 4.23M (in $), with an average decrease of 19.0% per quarter
  • Decreasing Net Profit

    Netprofit is down for the last 2 quarters, -34.21M → -45.62M (in $), with an average decrease of 33.4% per quarter
  • ABCL vs ONC (1 yr)

    In the last 1 year, Beone Medicines Ltd has given 69.1% return, outperforming this stock by 47.1%
  • ABCL vs ALNY (3 yr)

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 49.0% return, outperforming this stock by 115.1%
  • Price to Sales

    ForABCL every $1 of sales, investors are willing to pay $46.1, whereas for Beone Medicines Ltd, the investors are paying $6.1 for every $1 of sales.

Abcellera Biologics Technicals Summary

Sell

Neutral

Buy

Abcellera Biologics is currently in a neutral trading position according to technical analysis indicators.

Abcellera Biologics (ABCL) Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Abcellera Biologics Inc logo
68.69%
23.21%
29.86%
-65.22%
-93.87%
Regeneron Pharmaceuticals, Inc. logo
6.15%
-26.86%
-50.71%
-12.67%
-16.3%
Beone Medicines Ltd logo
-1.92%
30.58%
66.47%
24.02%
23.15%
Vertex Pharmaceuticals Incorporated logo
-0.93%
9.59%
-6.36%
52.71%
51.6%
Alnylam Pharmaceuticals, Inc. logo
5.47%
37.19%
32.68%
114.18%
115.41%

About Abcellera Biologics

AbCellera Biologics Inc. engages in discovering and developing antibody-based medicines for indications with unmet medical need in the United States. Its product pipeline includes ABCL635, an antibody-drug candidate, which is in preclinical trial to treat metabolic and endocrine conditions; and ABCL575, a fully human, half-life extended monoclonal antibody, which is in preclinical trial for treating T-cell-mediated autoimmune conditions, such as atopic dermatitis. The company has a research collaboration and license agreement with Eli Lilly and Company; and partnership agreement with Viking Global Investors & ArrowMark Partners and Biogen Inc. AbCellera Biologics Inc. was incorporated in 2012 and is headquartered in Vancouver, Canada.
Organization
Abcellera Biologics
Employees
596
CEO
Dr. Carl L.G. Hansen Ph.D.
Industry
Healthcare

Management People of Abcellera Biologics

NameTitle
Dr. Carl L.G. Hansen Ph.D.
CEO, President & Chairperson
Mr. Andrew Booth M.B.A.
Chief Financial Officer
Dr. Veronique Lecault Ph.D.
CTO & Director
Mr. Tryn T. Stimart Esq., J.D., M.Sc.
Chief Legal Officer, CCO, Compliance Officer, Corporate Secretary & Privacy Officer
Marcie Thiessen CPA, CGA
Senior Director of Finance & Accounting
Ms. Tiffany Chiu B.Sc., Ph.D.
Vice President of Communications
Graham Craig M.Sc.
Director of Corporate Development
Mr. Murray McCutcheon Ph.D.
Senior Vice President of Partnering
Mr. Neil Aubuchon B.A., M.B.A.
Chief Commercial Officer
Mr. Adam Clarke M.A.I.C.D., Ph.D.
Senior Vice President of Discovery

Important FAQs about investing in ABCL Stock from India :

Can Indians buy Abcellera Biologics shares?

Yes, Indians can invest in the Abcellera Biologics (ABCL) from India.

With INDmoney, you can buy Abcellera Biologics at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Abcellera Biologics at zero transaction cost.

How can I buy Abcellera Biologics shares from India?

It is very easy to buy Abcellera Biologics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Abcellera Biologics (ABCL) be purchased?

Yes, you can buy fractional shares of Abcellera Biologics with INDmoney app.

What are the documents required to start investing in Abcellera Biologics stocks?

To start investing in Abcellera Biologics, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What is Abcellera Biologics share price today?

Abcellera Biologics share price today stands at $3.42, Open: $3.64 ; Previous Close: $3.61 ; High: $3.75 ; Low: $3.42 ; 52 Week High: $4.09 ; 52 Week Low: $1.89.

The stock opens at $3.64, after a closing price of $3.61. The stock reached a daily high of $3.75 and a low of $3.42, with a 52-week high of $4.09 and a 52-week low of $1.89.

What are today’s High and Low prices of Abcellera Biologics Stock (ABCL)?

Today’s highest price of Abcellera Biologics (ABCL) is $3.75.

Today’s lowest price of Abcellera Biologics (ABCL) is $3.42.

What is the 52 Week High and Low Range of Abcellera Biologics Stock (ABCL)?

  • 52 Week High

    $4.09

  • 52 Week Low

    $1.89

What are the historical returns of Abcellera Biologics (ABCL)?

  • 1 Month Returns

    68.69%

  • 3 Months Returns

    23.21%

  • 1 Year Returns

    29.86%

  • 5 Years Returns

    -93.87%

What is today's market capitalisation of Abcellera Biologics?

Today's market capitalisation of Abcellera Biologics ABCL is 1.1B

Who is the Chief Executive Officer (CEO) of Abcellera Biologics ?

Dr. Carl L.G. Hansen Ph.D. is the current Chief Executive Officer (CEO) of Abcellera Biologics.